Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bleicher, R. J.
Right arrow Articles by Bilchik, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bleicher, R. J.
Right arrow Articles by Bilchik, A. J.
Related Collections
Right arrow Ablative therapies
Right arrow Surgery
Annals of Surgical Oncology 10:52-58 (2003)
© 2003 Society of Surgical Oncology


ORIGINAL ARTICLES

Radiofrequency Ablation in 447 Complex Unresectable Liver Tumors: Lessons Learned

Richard J. Bleicher, MD, David P. Allegra, MD, Dean T. Nora, MD, Thomas F. Wood, MD, Leland J. Foshag, MD and Anton J. Bilchik, MD, PhD

From the John Wayne Cancer Institute at Saint John’s Health Center (RJB, DTN, TFW, LJF, AJB), Santa Monica, California; and the Cancer Center at Century City Hospital (DPA, LJF, AJB), Los Angeles, California.

Correspondence: Address correspondence and reprint requests to: Anton Bilchik, MD, John Wayne Cancer Institute, 2200 Santa Monica Blvd., Santa Monica, CA 90404; Fax: 310-449-5261; E-mail: bilchika{at}jwci.org

Background: Radiofrequency ablation (RFA) is a promising technique for unresectable hepatic malignancies. We reviewed our RFA experience to identify variables affecting local recurrence.

Methods: Patients undergoing RFA between 1997 and 2001 were reviewed for demographics, tumor size, pathology, diagnosis, recurrence, procedures, survival, and complications.

Results: The 447 unresectable liver tumors were ablated in 198 procedures. The 153 patients averaged 61.9 years of age and 1.25 RFA procedures per patient. Follow-up averaged 11 months. Serial ablations were performed in 28 patients, 8 of whom are without evidence of disease. Tumors were most commonly carcinomas of colorectal, hepatocellular, breast, and melanoma histologies. Colorectal carcinomas and hepatomas individually recurred more frequently than all other tumor types combined in univariate analyses (P = .009 and P = .008, respectively). Patients with multiple tumors ablated recurred significantly more frequently (P = .001). Size was also significant in univariate and multivariate analyses (P = .0032 and <.0001, respectively). Eighteen patients experienced 36 complications.

Conclusions: Size has the highest correlation with local recurrence, but multiple tumors and pathology may also predict local recurrence risk. Large, complex lesions can be safely serially ablated, but because of morbidity and recurrence, RFA should not replace resection as the primary treatment of resectable liver tumors.

Key Words: Radiofrequency ablation • Hepatic metastases • Recurrence • Serial ablations




This article has been cited by other articles:


Home page
Arch SurgHome page
M. R. Khan, R. T. P. Poon, K. K. Ng, A. C. Chan, J. Yuen, H. Tung, J. Tsang, and S. T. Fan
Comparison of Percutaneous and Surgical Approaches for Radiofrequency Ablation of Small and Medium Hepatocellular Carcinoma
Arch Surg, December 1, 2007; 142(12): 1136 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
P. Kornprat, W. R. Jarnagin, R. P. DeMatteo, Y. Fong, L. H. Blumgart, and M. D'Angelica
Role of Intraoperative Thermoablation Combined With Resection in the Treatment of Hepatic Metastasis From Colorectal Cancer
Arch Surg, November 1, 2007; 142(11): 1087 - 1092.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
M.-H. Chen, W. Wu, W. Yang, Y. Dai, W. Gao, S.-S. Yin, and K. Yan
The Use of Contrast-Enhanced Ultrasonography in the Selection of Patients With Hepatocellular Carcinoma for Radio Frequency Ablation Therapy
J. Ultrasound Med., August 1, 2007; 26(8): 1055 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Mulier, Y. Ni, L. Frich, F. Burdio, A. L. Denys, J.-F. De Wispelaere, B. Dupas, N. Habib, M. Hoey, M. C. Jansen, et al.
Experimental and Clinical Radiofrequency Ablation: Proposal for Standardized Description of Coagulation Size and Geometry
Ann. Surg. Oncol., April 1, 2007; 14(4): 1381 - 1396.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. J. M. Ruers, J. J. Joosten, B. Wiering, B. S. Langenhoff, H. M. Dekker, T. Wobbes, W. J. G. Oyen, P. F. M. Krabbe, and C. J. A. Punt
Comparison Between Local Ablative Therapy and Chemotherapy for Non-Resectable Colorectal Liver Metastases: A Prospective Study
Ann. Surg. Oncol., March 1, 2007; 14(3): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
E. K. Abdalla, R. Adam, A. J. Bilchik, D. Jaeck, J.-N. Vauthey, and D. Mahvi
Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement
Ann. Surg. Oncol., October 1, 2006; 13(10): 1271 - 1280.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
D. A. Gervais, R. S. Arellano, and P. R. Mueller
Percutaneous radiofrequency ablation of ovarian cancer metastasis to the liver: indications, outcomes, and role in patient management.
Am. J. Roentgenol., September 1, 2006; 187(3): 746 - 750.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
F. F. Amersi, A. McElrath-Garza, A. Ahmad, T. Zogakis, D. P. Allegra, R. Krasne, and A. J. Bilchik
Long-term Survival After Radiofrequency Ablation of Complex Unresectable Liver Tumors
Arch Surg, June 1, 2006; 141(6): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. B. Faries and D. L. Morton
The Promise of Metastasectomy in Melanoma
Ann. Surg. Oncol., May 1, 2006; 13(5): 607 - 609.
[Full Text] [PDF]


Home page
Arch SurgHome page
T. A. Aloia, J.-N. Vauthey, E. M. Loyer, D. Ribero, T. M. Pawlik, S. H. Wei, S. A. Curley, D. Zorzi, and E. K. Abdalla
Solitary Colorectal Liver Metastasis: Resection Determines Outcome
Arch Surg, May 1, 2006; 141(5): 460 - 467.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
K. K. Ng, C. M. Lam, R. T. Poon, T. W. Shek, D. W. Ho, and S. T. Fan
Safety limit of large-volume hepatic radiofrequency ablation in a rat model.
Arch Surg, March 1, 2006; 141(3): 252 - 258.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. K. Ng, C. M. Lam, R. T. Poon, T. W. Shek, W. C. Yu, J. Y. To, Y. H. Wo, C. P. Lau, T. C. Tang, D. W. Ho, et al.
Porcine Liver: Morphologic Characteristics and Cell Viability at Experimental Radiofrequency Ablation with Internally Cooled Electrodes
Radiology, May 1, 2005; 235(2): 478 - 486.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. Lieberman, E. Goldin, M. Lotem, and A. I. Bloom
Irrigation of the Bile Ducts with Chilled Saline During Percutaneous Radiofrequency Ablation of a Hepatic Ocular Melanoma Metastasis
Am. J. Roentgenol., September 1, 2004; 183(3): 596 - 598.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. K. Ng, C. M. Lam, R. T. Poon, T. W. Shek, J. Y. To, Y. H. Wo, D. W. Ho, and S. T. Fan
Comparison of Systemic Responses of Radiofrequency Ablation, Cryotherapy, and Surgical Resection in a Porcine Liver Model
Ann. Surg. Oncol., July 1, 2004; 11(7): 650 - 657.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
A. J. Bilchik and S. R. Martinez
Editorial: Novel Effective Drugs and Evolving Ablation Technology: A More Comprehensive Approach to Hepatic Malignancies
Ann. Surg. Oncol., May 1, 2004; 11(5): 458 - 459.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Elias, O. Baton, L. Sideris, T. Matsuhisa, M. Pocard, and P. Lasser
Local Recurrences After Intraoperative Radiofrequency Ablation of Liver Metastases: A Comparative Study with Anatomic and Wedge Resections
Ann. Surg. Oncol., May 1, 2004; 11(5): 500 - 505.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
W.-L. Yang, D. G. Nair, R. Makizumi, G. Gallos, X. Ye, R. R. Sharma, and T.S. Ravikumar
Heat Shock Protein 70 Is Induced in Mouse Human Colon Tumor Xenografts After Sublethal Radiofrequency Ablation
Ann. Surg. Oncol., April 1, 2004; 11(4): 399 - 406.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. A. Ahmad
Editorial: Limitations of Radiofrequency Ablation in Treating Liver Metastases: A Lesson in Geometry
Ann. Surg. Oncol., April 1, 2004; 11(4): 358 - 359.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. L. Stippel, H. G. Brochhagen, M. Arenja, J. Hunkemoller, A. H. Holscher, and K. T. E. Beckurts
Variability of Size and Shape of Necrosis Induced by Radiofrequency Ablation in Human Livers: A Volumetric Evaluation
Ann. Surg. Oncol., April 1, 2004; 11(4): 420 - 425.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
W. S. Helton
Editorial: Ocular Melanoma Metastatic to the Liver: The Role of Surgery in Multimodality Therapy
Ann. Surg. Oncol., March 1, 2004; 11(3): 242 - 244.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. Fuss and C. R. Thomas Jr.
Stereotactic Body Radiation Therapy: An Ablative Treatment Option for Primary and Secondary Liver Tumors
Ann. Surg. Oncol., February 1, 2004; 11(2): 130 - 138.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. M. Pawlik, F. Izzo, D. S. Cohen, J. S. Morris, and S. A. Curley
Combined Resection and Radiofrequency Ablation for Advanced Hepatic Malignancies: Results in 172 Patients
Ann. Surg. Oncol., November 1, 2003; 10(9): 1059 - 1069.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society of Surgical Oncology.